Dysport abobotulinumtoxinA: Phase III data

Top-line data from a double-blind, international Phase III trial in 388 adult hemiparetic patients with lower limb spasticity who experienced a stroke or traumatic brain injury (TBI) showed that 1,500 U Dysport met the primary endpoint of improving muscle tone as measured by MAS scores at week 4 vs. placebo (p<0.05). Dysport missed the secondary endpoint of improving PGA score vs. placebo. ...